TriangleFOR PATIENTS · SOURCE READING
Early Unfavorable
Source: Hodgkin Lymphoma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 27, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Stages of Hodgkin Lymphoma / Hodgkin lymphoma may be grouped for treatment as follows:
Early unfavorable Hodgkin lymphoma is stage I or stage II with one or more of the following risk factors that increase the chance that the cancer will come back after it is treated:
Source links and citations
Having a tumor in the chest that is larger than 1/3 of the width of the chest or is at least 10 centimeters.
Source links and citations
Having cancer in an organ other than the lymph nodes.
Source links and citations
Having a high sedimentation rate (in a sample of blood, the red blood cells settle to the bottom of the test tube more quickly than normal).
Source links and citations
Having three or more lymph nodes with cancer.
Having B symptoms (fever for no known reason, weight loss for no known reason, or drenching night sweats).
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice